The Myeloma Program at Moffitt Cancer Center specializes in the evaluation, treatment, and comprehensive care of patients with plasma cell disorders including multiple myeloma, solitary plasmacytomas, primary systemic amyloidosis, Waldenström's macroglobulinemia, and monoclonal gammopathy of undetermined significance.
Follow the links below to learn about multiple myeloma, its treatment, our multiple myeloma team, support options and research.
Additional Links
Learn More About Moffitt's Malignant Hematology (Mal Heme) Program
